Literature DB >> 35078371

Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association.

Connie W Tsao, Aaron W Aday, Zaid I Almarzooq, Alvaro Alonso, Andrea Z Beaton, Marcio S Bittencourt, Amelia K Boehme, Alfred E Buxton, April P Carson, Yvonne Commodore-Mensah, Mitchell S V Elkind, Kelly R Evenson, Chete Eze-Nliam, Jane F Ferguson, Giuliano Generoso, Jennifer E Ho, Rizwan Kalani, Sadiya S Khan, Brett M Kissela, Kristen L Knutson, Deborah A Levine, Tené T Lewis, Junxiu Liu, Matthew Shane Loop, Jun Ma, Michael E Mussolino, Sankar D Navaneethan, Amanda Marma Perak, Remy Poudel, Mary Rezk-Hanna, Gregory A Roth, Emily B Schroeder, Svati H Shah, Evan L Thacker, Lisa B VanWagner, Salim S Virani, Jenifer H Voecks, Nae-Yuh Wang, Kristine Yaffe, Seth S Martin.   

Abstract

BACKGROUND: The American Heart Association, in conjunction with the National Institutes of Health, annually reports the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors (smoking, physical activity, diet, and weight) and health factors (cholesterol, blood pressure, and glucose control) that contribute to cardiovascular health. The Statistical Update presents the latest data on a range of major clinical heart and circulatory disease conditions (including stroke, congenital heart disease, rhythm disorders, subclinical atherosclerosis, coronary heart disease, heart failure, valvular disease, venous disease, and peripheral artery disease) and the associated outcomes (including quality of care, procedures, and economic costs).
METHODS: The American Heart Association, through its Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States to provide the most current information available in the annual Statistical Update. The 2022 Statistical Update is the product of a full year's worth of effort by dedicated volunteer clinicians and scientists, committed government professionals, and American Heart Association staff members. This year's edition includes data on the monitoring and benefits of cardiovascular health in the population and an enhanced focus on social determinants of health, adverse pregnancy outcomes, vascular contributions to brain health, and the global burden of cardiovascular disease and healthy life expectancy.
RESULTS: Each of the chapters in the Statistical Update focuses on a different topic related to heart disease and stroke statistics.
CONCLUSIONS: The Statistical Update represents a critical resource for the lay public, policymakers, media professionals, clinicians, health care administrators, researchers, health advocates, and others seeking the best available data on these factors and conditions.

Entities:  

Keywords:  AHA Scientific Statements; cardiovascular diseases; epidemiology; risk factors; statistics; stroke

Mesh:

Year:  2022        PMID: 35078371     DOI: 10.1161/CIR.0000000000001052

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   39.918


  171 in total

1.  Leveraging Mammography as a Unique Opportunity for Cardiovascular Health Promotion.

Authors:  Natalie A Cameron; Sadiya S Khan
Journal:  Circ Cardiovasc Imaging       Date:  2022-03-15       Impact factor: 7.792

2.  Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Identifies Abnormal Calf Muscle-Specific Energetics in Peripheral Artery Disease.

Authors:  Helen L Sporkin; Toral R Patel; Yaqub Betz; Roshin Mathew; Christopher L Schumann; Craig H Meyer; Christopher M Kramer
Journal:  Circ Cardiovasc Imaging       Date:  2022-07-19       Impact factor: 8.589

3.  Disparities in Cardiovascular Mortality Between Black and White Adults in the United States, 1999 to 2019.

Authors:  Ashley N Kyalwazi; Eméfah C Loccoh; LaPrincess C Brewer; Elizabeth O Ofili; Jiaman Xu; Yang Song; Karen E Joynt Maddox; Robert W Yeh; Rishi K Wadhera
Journal:  Circulation       Date:  2022-07-18       Impact factor: 39.918

Review 4.  SAMSON and the Nocebo Effect: Management of Statin Intolerance.

Authors:  Amrita Krishnamurthy; Corey Bradley; Rebecca Ascunce; Samuel M Kim
Journal:  Curr Cardiol Rep       Date:  2022-06-27       Impact factor: 3.955

5.  Metabolomic Characterization of Acute Ischemic Stroke Facilitates Metabolomic Biomarker Discovery.

Authors:  Biao Qi; Yanyu Zhang; Bing Xu; Yuhao Zhang; Guoqiang Fei; Ling Lin; Qiuping Li
Journal:  Appl Biochem Biotechnol       Date:  2022-07-05       Impact factor: 3.094

Review 6.  Signaling through Free Fatty Acid Receptor 4 Attenuates Cardiometabolic Disease.

Authors:  Timothy D O'Connell; Katherine A Murphy; Naixin Zhang; Sara J Puccini; Chastity L Healy; Brian A Harsch; Michael J Zhang; Gregory C Shearer
Journal:  Physiology (Bethesda)       Date:  2022-08-09

Review 7.  Recent advances in targeted delivery of non-coding RNA-based therapeutics for atherosclerosis.

Authors:  Xiaoxin Li; Hongzhao Qi; Weigang Cui; Zhibin Wang; Xiuxiu Fu; Tianxiang Li; Huibo Ma; Yanyan Yang; Tao Yu
Journal:  Mol Ther       Date:  2022-08-01       Impact factor: 12.910

Review 8.  Cardiac and Vascular Causes of Syncope and Atherosclerosis.

Authors:  Rose Mary Ferreira Lisboa da Silva; Josep Brugada
Journal:  Curr Cardiol Rep       Date:  2022-08-01       Impact factor: 3.955

Review 9.  Empagliflozin for Patients with Heart Failure and Type 2 Diabetes Mellitus: Clinical Evidence in Comparison with Other Sodium-Glucose Co-transporter-2 Inhibitors and Potential Mechanism.

Authors:  Bo Liang; Rui Li; Peng Zhang; Ning Gu
Journal:  J Cardiovasc Transl Res       Date:  2022-08-15       Impact factor: 3.216

Review 10.  Research and application advances in rehabilitation assessment of stroke.

Authors:  Kezhou Liu; Mengjie Yin; Zhengting Cai
Journal:  J Zhejiang Univ Sci B       Date:  2022-08-15       Impact factor: 5.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.